| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |